Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2000 Nov;17(10):586-90.
doi: 10.1023/a:1026491426423.

Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study

B Urman  1 , R Mercan, C Alatas, B Balaban, A Isiklar, A Nuhoglu
Affiliations
Clinical Trial

Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study

B Urman et al. J Assist Reprod Genet. 2000 Nov.

Abstract

Purpose: The aim was to evaluate the effect of aspirin on pregnancy and implantation rates in an unselected group of patients undergoing intracytoplasmic sperm injection (ICSI).

Methods: Two hundred and seventy-nine patients were randomized to receive 80 mg of aspirin (n = 139) or no treatment (r = 136) starting from the first day of controlled ovarian hyperstimulation.

Results: Duration of stimulation, gonadotropin consumption, peak estradiol, number of oocytes retrieved, fertilization rate, cleavage rate, and number of embryos transferred were similar in the two groups. Implantation and clinical pregnancy rates were 15.6% and 39.6% versus 15.1% and 43.4% in aspirin treated and untreated groups, respectively (P > 0.05).

Conclusions: Low-dose aspirin administration does not improve implantation and pregnancy rates in an unselected group of patients undergoing ICSI.

PubMed Disclaimer

References

    1. HC K., CC H., ST W. Aspirin improves uterine blood flow in the peri-implantation period. J Formos Med Assoc. 1997;96:253–257. - PubMed
    1. Sher G, Feinman M, Zouves C, Kuttner G, Massarani G, Salem R, Mater W, Chong P. High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod. 1994;9:2278–2283. - PubMed
    1. Balasch J, Creus M, Fabregues F, Reverter JC, Carmana F, Tassies D, Font J, Vanrell JA. Antiphospholipid antibodies and human reproductive failure. Hum Reprod. 1996;11:2310–2315. - PubMed
    1. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: Role of heparin and aspirin. Hum Reprod. 1997;12:1171–1175. - PubMed
    1. Wada I, Hsu CC, Williams G, Macnamee MC, Brindsen PR. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted reproduction. Hum Reprod. 1994;9:1954–1957. - PubMed

Publication types

LinkOut - more resources